Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs
Tóm tắt
Tetracyclines have long been considered useful adjuncts in peridontal therapy based on their antimicrobial efficacy against putative periodontopathogens. However, recently these drugs were found to inhibit mammalian collagenases and several other matrix metalloproteinases (MMPs) by a mechanism independent of their antimicrobial activity. Evidence is presented that this property may be therapeutically useful in retarding pathologic connective tissue breakdown, including bone resorption. The experiments leading to this discovery are described and possible mechanisms are addressed, including the specificity of tetracyclines' anti-collagenase activity, the role of the drugs' metal ion (Zn2+, Ca2+)- binding capacity, and the site on the tetracycline molecule responsible for this nonantimicrobial property. Of extreme interest, the tetracycline molecule has been chemically modified in multiple ways, generating a new family of compounds called CMTs (chemically modified tetracyclines) that lack antimicrobial but still retain anti-collagenase activity. The first of these CMTs, 4-de-dimethylaminotetracycline, was found not to produce a major side-effect of antimicrobial tetracycline therapy- its administration to experimental animals did not result in the emergence of tetracycline-resistant microorganisms in the oral flora and gut. Numerous examples of the clinical potential of this non-antimicrobial property of tetracyclines in the treatment of periodontal and several medical diseases (e.g., sterile corneal ulcers, rheumatoid arthritis, skin bullous lessions, tumor-induced angiogenesis and metastasis) are discussed.
Từ khóa
Tài liệu tham khảo
Park, J.K. and Dow, R.C., The uptake and localization of tetracycline in human blood cells, Br. J. Exp. Pathol., 51, 179, 1970.
Lynch, W.S. and Bergfeld, W.F., Pyoderma gangrenosum responsive to minocycline hydrochloride, Cutis, 21, 535, 1978.
Humbert, P., Renaud, A., Laurent, L., and Agache, P., Tetracyclines for dystrophic epidermolysis bullosa, Lancet, 1, 277, 1989.
Golub, L.M., Greenwald, R.A., Zebrowski, E.J., and Ramamurthy, N.S., The effect of experimental diabetes on the molecular characteristics of rat tail tendon collagen, Biochim. Biophys. Acta, 534, 73, 1978.
Clark, R.A., Page, R.C., and Wilde, C., Defective neutrophil chemotaxis in juvenile periodontitis, Infect. Immun., 12, 694, 1977.
Ramamurthy, N.S. and Golub, L.M., Diabetes increases collagenase activity in extracts of rat gingiva and skin, J. Periodont. Res., 17, 455, 1983.
Golub, L.M., Ramamurthy, N.S., Kaneko, H., Sasaki, T., Rifkin, B., and McNamara, T.F., Tetracycline administration prevents diabetes-induced osteopenia in the rat: initial observations, Res. Commun. Chem. Pathol. Pharmacol., 68, 27, 1990.
Ramsammy, L., Ramamurthy, N., Greenwald, R., Arbeit, L., and Golub, L.M., Tetracycline administration ameliorates diabetic rat kidney dysfunction, Kidney Int., submitted.
Burns, F.R., Stack, M.S., Gray, R.D., and Paterson, C.A., Inhibition of purified collagenase from alkaline-burned rabbit corneas, Invest. Opthalmol. Vis. Sci., 30, 1569, 1989.
Greenwald, R.A., Golub, L.M., Laveites, B., Ramamurthy, N.S., Laskin, R., and Gruber, B., Tetracyclines inhibit human synovial collagenase in vivo and in vitro, J. Rheumatol., 14, 28, 1987.
Ramamurthy, N.S., Vernillo, A., Lee, H.M., Golub, L.M., and Rifkin, B.R., The effect of tetracyclines on collagenase activity in UMR 106-01 rat osteoblastic osteosarcoma cells, Res. Commun. Chem. Pathol. Pharmacol., 70, 323, 1990.
Perry, H.D., Hodes, L.W., Seedor, J.A., Donnenfeld, E.D., McNamara, T.F., and Golub, L.M., Effect of doxycycline hyclate on corneal epithelial wound healing in the rabbit alkali-burn model, Ann. Ohpthalmol., submitted.
Zucker, S., Lysik, R.M., Ramamurthy, N.S., Golub, L.M., Wieman, J.M., and Wilkie, D.P., Diversity of plasma membrane proteinases in mouse melanoma cells: inhibition of collagenolytic and cytolytic activity by minocycline, J. Natl. Cancer Inst., 75, 517, 1985.
Zucker, S., Wieman, J., Lysik, R.M., Imhof, B., Nagase, H., Ramamurthy, N.S., Liotta, L.A., and Golub, L.M., Gelatin-degrading type IV collagenase isolated from human small cell lung cancer, Invas. Metast., 9, 167, 1989.
Yanagimura, M., Koike, F., and Hara, K., Collagenase activity in gingival crevicular fluid and inhibition by tetracyclines, J. Dent. Res., 68 (Spec. Iss.), 1691, 1989.
Ramamurthy, N.S., Lee, H.M., Vidal, A.M., McNamara, T.F., Rifkin, B., and Golub, L.M., The substantivity of the anti-collagenase activity of minocycline in vivo, J. Dent. Res., 65 (Spec. Iss.), IADR Abstr. no. 1015, 1986.
Greenwald, R.A., Tetracycline derivatives as potential inhibitors of connective tissue degradation, Drug News Perspect., 3, 161, 1990.
Golub, L.M., Greenwald, R., Ramamurthy, N., Zucker, S., Ramsammy, L., and McNamara, T., Tetracyclines inhibit metalloproteinases: in vivo effects in arthritic and diabetic rats and new in vitro studies, in Matrix Metalloproteinase Conference, Proceedings, Destin, FL, Abstr. no. 63, p. 43, Sept. 11-15, 1989.
Lee, H.M., Golub, L., Suzuki, K., Nagase, H., Sorsa, T., Uitto, V.J., and Ramamurthy, N., Specificity of the anti-collagenase activity of tetracyclines, J. Dent. Res., 70 (Spec. Iss.), IADR Abstr. no. 1621, 1991.
Chang, K.M., Ramamurthy, N.S., and Golub, L.M., Minocycline inhibits matrix-degrading enzymes in rat gingiva, J. Dent. Res., 68 (Spec. Iss.), AADR Abstr. no. 130, 1989.
Lee, H.M., Golub, L.M., Gwinnett, A.J., and Ramamurthy, N.S., Minocycline inhibits collagenase and elastase produced by rat macrophages in cell culture, J. Dent. Res., 64 (Spec. Iss.), IADR Abstr. no. 1175, 1985.
Arsenis, C., Greenwald, R.A., Moak, S.A., and Laskin, R.S., Inhibition of neutral metalloproteinase activities in epiphyseal and articular cartilages by tetracyclines both in vivo and in vitro, Trans. Orthopaed. Res. Soc., 15, 268, 1990.
Boothe, J.H., Bonvicino, G.E., Waller, C.W., Petisi, J.P., Wilkinson, R.W., and Broschard, R.B., Chemistry of the tetracycline antibiotics. I. Quaternary derivatives, J. Am. Chem. Soc., 80, 1654, 1958.
McNamara, T.F., Golub, L.M., D'Angelo, G., and Ramamurthy, N.S., The synthesis and characterization of a non-antibacterial chemically-modified tetracycline (CMT), J. Dent. Res., 65 (Spec. Iss.), IADR Abstr. no. 515, 1986.
McNamara, T.F., Golub, L.M., Yu, Z., and Ramamurthy, N., Chemically modified tetracyclines (CMTs) fail to induce microbial resistance, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1091, 1990.
Rifkin, B., Sanavi, F., Gomes, B., Kleckner, A., McNamara, T., Ramamurthy, N., and Golub, L., The effects of minocycline and non-antibiotic tetracycline on parathyroid hormone stimulated bone resorption in vitro, J. Bone Min. Res., 1991, submitted.
Seltzer, J.L., Eschback, M.L., Winberg, J. 0., Bauer, E.A., Eisen, A.Z., and Weingarten, H., Eriochrome black T inhibition of human skin collagenase, but not gelatinase, using both protein and synthetic substrates, Collagen Rel. Res., 7, 399, 1987.
Valcavi, U., Companella, G., and Pacini, N., Pirazol-derivati della tetracyclina e clorotetraciclina, Gazz. Chem. Ital., 93, 916, 1963.
Skinner, H.C.W. and Nalbandian, J., Tetracycline and mineralized tissue, Yale J. Biol. Med., 48, 377, 1975.
Karakiulakis, G., Missirlis, E., and Margoudakis, M.E., Mode of action of Razoxane: inhibition of basement membrane collagen-degradation by a malignant tumor enzyme, Methods Find. Exp. Clin. Pharmacol., 11, 255, 1989.
Ramamurthy, N.S., Lee, H., Vidal, A., McNamara, T., and Golub, L., Effect of non-antimicrobial tetracycline on gingivitis and collagenase activity in ODU-rats, J. Dent. Res., 68 (Spec. Iss.), AADR Abstr. no. 1840, 1989.
Yu, Z., Leung, M., Ramamurthy, N., McNamara, T., and Golub, L., Serum levels of chemically-modified tetracycline: a comparison to tetracycline, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1092, 1990.
Klausen, B., Evans, R.T., Ramamurthy, N.S., Golub, L.M., Sfintescu, C., Lee, Y.J., Bedi, G., Zambon, J.J., and Genco, R.J., Reduced periodontal bone loss in gnotobiotic rats immunized with Bacteroides gingivalis, J. Oral Microbiol. Immunol., in press.
Chang, K.M., Ramamurthy, N.S., Yu, Z., NcNamara, T.F., and Golub, L.M., Effect of tetracyclines on B. gingivalis - induced alveolar bone loss in rats, J. Dent. Res., 70 (Spec. Iss.), IADR Abstr. no. 1620, 1991.
Yu, Z., Schneir, M., Ramamurthy, N., Leung, M., and McNamara, T., Chemically modified tetracycline prevents collagen loss in diabetic rats: intracellular and extra-cellular mechanisms, J. Dent. Res., 70 (Spec. Iss.), Abstr. no. 1619, 1991.
Golub, L.M., Goodson, J.M., Lee, H.M., Vidal, A.M., McNamara, T.F., and Ramamurthy, N.S., Locally and low-dose systemically administered tetracyclines inhibit tissue collagenase activity: potential new approaches in the treatment of periodontal disease, J. Periodontol., 56, (Spec. Iss.), 93, 1985.
Lamster, I., Celenti, R., and Silver, F., A new assay for collagenolytic activity in crevicular fluid, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1738, 1990.
Schroeder, K., Lee, H., Wolff, M., Ramamurthy, N., and Golub, L.M., Low-dose tetracyclines decrease elastase and β-glucuronidase activities in gingival crevicular fluid, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1090, 1990.
Gabler, W.L. and Creamer, H.C., Effects of tetracycline derivatives on neutrophil functions, J. Dent. Res., 69 (Spec. Iss.), IADR Abstr. no. 1089, 1990.
Chang, C. and Houck, J.C., Demonstration of the chemotactic properties of collagen, Proc. Soc. Exp. Biol., 134, 22, 1974.
Golub, L.M., Wolff, M., Vidal, A.M., Ramamurthy, N.S., and McNamara, T.F., Low-dose minocycline therapy: effects on crevicular fluid collagenase and subgingival microflora, J. Dent. Res., 66 (Spec. Iss.), IADR Abstr. no. 384, 1987.
Cowen, K.S., Sakamoto, M., and Sakamoto, S., Monensin inhibits collagenase production in osteoblastic cell cultures and also inhibits both collagenase release and bone resorption in mouse calvaria cultures, Biochem. Int., 11, 273, 1985.
Sakamoto, M. and Sakamoto, S., Immunocytochemical localization of collagenase in isolated mouse bone cells, Biomed. Res., 5, 29, 1984.
Otsuka, K., Sodek, J., and Limeback, H., Synthesis of collagenase and collagenase inhibitors by osteoblast-like cells in culture, Eur. J. Biochem., 145, 123, 1984.
Chambers, T.J., Darby, J.A., and Fuller, K., Mammalian collagenase predisposes bone surfaces to osteoclastic resorption, Cell Tissue Res., 241, 671, 1985.
Baron, R., Eeckhout, Y., Neff, L., Francois-Gillet, C., Henriet, P., Delaisse, J.M., and Vaes, G., Affinity purified antibodies reveal the presence of procollagenase in the subosteoclastic bone resorbing compartment, J. Bone Miner. Res., 5 (Suppl. 2), S203, 1990.
Donahue, H., Iijima, K., Gdigorsky, M., Rubin, C., and Rifkin, G., Tetracycline alters the regulation of cytoplasmic calcium ion in rat osteoclasts, J. Bone Miner. Res. (Abstr.), 1990, in press.
Shires, R., Teitelbaum, S.L., Bergfeld, M.A., Fallon, M.D., Slatopolsky, E., and Avioli, L.V., The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat, J. Lab. Clin. Med., 97, 231, 1981.
Sasaki, T., Kaneko, H., Ramamurthy, N.S., and Golub, L.M., Tetracycline administration normalizes osteoblast structure and function during experimental diabetes, Anat. Rec., 1991, in press.
Bain, S., Ramamurthy, N., Impeduglia, T., Scolman, S., Golub, L., and Rubin, C., Tetracycline treatment normalizes bone formation in the diabetic rat: a histomorphometric study, J. Bone Miner. Res., 1990, submitted.
Sasaki, T., Ramamurthy, N.S., and Golub, L.M., Insulin-deficient diabetes impairs osteoblast and periodontal ligament fibroblast metabolism but does not affect ameloblasts and odontoblasts: response to tetracycline(s) adminstration, J. Biol. Buccale, 18, 215, 1990.
Kao, W.W.Y., Mai, S.H., Chu, K.L., and Ebert, J., Mechanism for the regulation of post-translational modification of procollagens synthesized by matrix-free cells from chick embryos, J. Biol. Chem., 258, 7779, 1983.
Perry, H.D. and Golub, L.M., Systemic-tetracycline in the treatment of non-infected corneal ulcers, Ann. Ohpthalmol., 17, 742, 1985.
Szmyd, L., Spector, S.M., Perry, H.D., Seedor, J.A., McNamara, T.F., and Golub, L.M., Topical tetracycline in the treatment of alkali induced corneal ulceration in the rabbit, Invest. Ohpthalmol., 27 (Suppl.), 208, 1986.
Levy, J.H. and Katz, H.R., Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit, Ann. Ohpthalmol., 22, 179, 1990.
Greenwald, R.A., Golub, L.M., Ramamurthy, N.S., and McNamara, T.F., Direct detection of collagenase and gelatinase in periarticular tissue from adjuvant arthritic rats: inhibition by tetracyclines and potential amelioration of bone destruction, Trans. Orthopaed. Res. Soc., 15, 270, 1990.
Breedveld, F.C., Dijkmans, B.A.C., and Mattie, H., Minocycline treatment for rheumatoid arthritis: an open dose finding study, J. Rheumatol., 17, 43, 1990.
Ramsammy, L., Ramamurthy, N., Lee, H., Greenwald, R., and Golub, L., Tetracycline inhibits diabetic rat kidney type IV collagenolytic activity and proteinuria, Clin. Res., 37, 459A, 1989.
Lin, A.N., Stem, R.S., Caldwell-Brown, D., and Carter, D.M., Phenytoin for recessive dystrophic epidermolysis bullosa, J. Invest. Dermatol., 92 (Abstr.) 1989, 472.
Karakiulakis, G., Missirlis, E., and Maragoudakis, M.E., Mode of action of Razoxane: inhibition of basement membrane collagen-degradation by a malignant tumor enzyme, Methods Find. Exp. Clin. Pharmacol., 11, 255, 1989.
Tamargo, R.J., Bok, R.A., and Brem, H., Angiogenesis inhibition by minocycline, Cancer, Res., 51, 672, 1991.